Intestinal ischemia/reperfusion injury: Defining the role of the gut microbiome

Biomarkers in Medicine

Volumn 3, Issue 2, 2009, Pages 175-192

  Kinross, James ^a   Warren, Oliver ^a   Basson, Sonia ^b   Holmes, Elaine ^a   Silk, David ^a   Darzi, Ara ^a   Nicholson, Jeremy K ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

Intestine; Ischemia; Metabonomics; Microbiome; Reperfusion; Systems biology

Indexed keywords

BIOLOGICAL MARKER;

ACTINOBACTERIA; BACTEROIDETES; DIAGNOSTIC VALUE; FIRMICUTES; GENOMICS; HUMAN; INTESTINE FLORA; INTESTINE INJURY; INTESTINE ISCHEMIA; METABOLOMICS; MICROBIOME; MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOGENESIS; PROGNOSIS; PROTEOBACTERIA; PROTEOMICS; QUANTITATIVE ANALYSIS; REPERFUSION INJURY; REVIEW; SYMBIOSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; SYSTEMS BIOLOGY;

MAMMALIA;

EID: 68049086570     PISSN: 17520363     EISSN: None     Source Type: Journal    
DOI: 10.2217/bmm.09.11     Document Type: Review

References (129)

1. Parks DA, Granger DN: Ischemia-reperfusion injury: a radical view. Hepatology 8, 680-682 (1988).
2. Simpson R, Alon R, Kobzik L, Valeri CR, Shepro D, Hechtman HB: Neutrophil and non neutrophil-mediated injury in intestinal ischemia-reperfusion. Ann. Surg. 218, 444-453; discussion 453-454 (1993).
3. Andersson B, Nilsson J, Brandt J, Hoglund P, Andersson R: Gastrointestinal complications after cardiac surgery. Br. J. Surg. 92, 326-333 (2005).
4. Bjorck M, Bergqvist D, Troeng T, Haglund U, Hedberg B: Intestinal ischemia after abdominal aorta surgery. A dreaded complication surveyed by a combination of different methods. Lakartidningen 96, 3659-3662 (1999).
5. Horton JW: Bacterial translocation after burn injury: the contribution of ischemia and permeability changes. Shock 1, 286-290 (1994).
6. Haglund U: Gut ischaemia. Gut 35, S73-S76 (1994).
7. Kurland B, Brandt LJ, Delany HM: Diagnostic tests for intestinal ischemia. Surg. Clin. North Am. 72, 85-105 (1992).
8. Park WM, Gloviczki P, Cherry KJ Jr et al.: Contemporary management of acute mesenteric ischemia: factors associated with survival. J. Vasc. Surg. 35, 445-452 (2002).
9. Yasuhara H, Niwa H, Takenoue T, Naka S: Factors influencing mortality of acute intestinal infarction associated with SIRS. Hepatogastroenterology 52, 1474-1478 (2005).
10. Alverdy JC, Laughlin RS, Wu L: Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Crit. Care Med. 31, 598-607 (2003).
11. Lederberg J: Infectious history. Science 288, 287-293 (2000).
12. Dethlefsen L, McFall-Ngai M, Relman DA: An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 449, 811-818 (2007).
13. Nicholson JK, Lindon JC, Holmes E: 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 29, 1181-1189 (1999).
14. Nicholson JK, Connelly J, Lindon JC, Holmes E: Metabonomics: a platform for studying drug toxicity and gene function. Nat. Rev. Drug Discov. 1, 153-161 (2002).
15. 1H NMR spectroscopy based metabonomics for large-scale epidemiological research: the INTERMAP Study. Anal. Chem. 78, 2199-2208 (2006).
16. 1H-NMR-based metabonomics. Nat. Med. 8, 1439-1444 (2002).
17. Marchesi JR, Holmes E, Khan F et al.: Rapid and noninvasive metabonomic characterization of inflammatory bowel disease. J. Proteome Res. 6, 546-551 (2007).
18. Kruglyak L: The road to genome-wide association studies. Nat. Rev. Genet. 9, 314-318 (2008).
19. Holmes E, Loo RL, Stamler J et al.: Human metabolic phenotype diversity and its association with diet and blood pressure. Nature 453, 396-400 (2008).
20. Kell DB: Metabolomics and systems biology: making sense of the soup. Curr. Opin Microbiol. 7, 296-307 (2004).
21. Kitano H: Computational systems biology. Nature 420, 206-210 (2002).
22. Zelena E, Dunn WB, Broadhurst D et al.: Development of a robust and repeatable UPLC-MS method for the long-term metabolomic study of human serum. Anal. Chem. 81, 1357-1364 (2009).
23. Rezzi S, Vera FA, Martin FP, Wang S, Lawler D, Kochhar S: Automated SPE-RP-HPLC fractionation of biofluids combined to off-line NMR spectroscopy for biomarker identification in metabonomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 871, 271-278 (2008).
24. Guy PA, Tavazzi I, Bruce SJ, Ramadan Z, Kochhar S: Global metabolic profiling analysis on human urine by UPLC-TOFMS: issues and method validation in nutritional metabolomics. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 871, 253-260 (2008).
25. Deitch EA: Bacterial translocation or lymphatic drainage of toxic products from the gut: what is important in human beings? Surgery 131, 241-244 (2002).
26. Koury J, Deitch EA, Homma H et al.: Persistent HIF-1α activation in gut ischemia/reperfusion injury: potential role of bacteria and lipopolysaccharide. Shock 22, 270-277 (2004).
27. Chen LW, Egan L, Li ZW, Greten FR, Kagnoff MF, Karin M: The two faces of IKK and NF-κB inhibition: prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion. Nat. Med. 9, 575-581 (2003).
28. Adams CA Jr, Sambol JT, Xu DZ, Lu Q, Granger DN, Deitch EA: Hemorrhagic shock induced upregulation of P-selectin expression is mediated by factors in mesenteric lymph and blunted by mesenteric lymph duct interruption. J. Trauma 51, 625-631; discussion 631-632 (2001).
29. Adams JM, Hauser CJ, Adams CA Jr, Xu DZ, Livingston DH, Deitch EA: Entry of gut lymph into the circulation primes rat neutrophil respiratory burst in hemorrhagic shock. Crit. Care Med. 29, 2194-2198 (2001).
30. Caruso JM, Feketeova E, Dayal SD, Hauser CJ, Deitch EA: Factors in intestinal lymph after shock increase neutrophil adhesion molecule expression and pulmonary leukosequestration. J. Trauma 55, 727-733 (2003).
31. Magnotti LJ, Upperman JS, Xu DZ, Lu Q, Deitch EA: Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann. Surg. 228, 518-527 (1998).
32. Reddy BS, MacFie J, Gatt M, Macfarlane-Smith L, Bitzopoulou K, Snelling AM: Commensal bacteria do translocate across the intestinal barrier in surgical patients. Clin. Nutr. 26, 208-215 (2007).
33. MacFie J, Reddy BS, Gatt M, Jain PK, Sowdi R, Mitchell CJ: Bacterial translocation studied in 927 patients over 13 years. Br. J. Surg. 93, 87-93 (2006).
34. Cavriani G, Domingos HV, Oliveira-Filho RM, Sudo-Hayashi LS, Vargaftig BB, de Lima WT: Lymphatic thoracic duct ligation modulates the serum levels of IL-1β and IL-10 after intestinal ischemia/reperfusion in rats with the involvement of tumor necrosis factor a and nitric oxide. Shock 27, 209-213 (2007).
35. Zimmerman BJ, Granger DN: Mechanisms of reperfusion injury. Am. J. Med. Sci. 307, 284-292 (1994).
36. Granger DN, Hollwarth ME, Parks DA: Ischemia-reperfusion injury: role of oxygen-derived free radicals. Acta Physiol. Scand. Suppl. 548, 47-63 (1986).
37. Horton JW, Walker PB: Oxygen radicals, lipid peroxidation, and permeability changes after intestinal ischemia and reperfusion. J. Appl. Physiol. 74, 1515-1520 (1993).
38. Zimmerman BJ, Granger DN: Oxygen free radicals and the gastrointestinal tract: role in ischemia-reperfusion injury. Hepatogastroenterology 41, 337-342 (1994).
39. Yeh KY, Yeh M, Glass J, Granger DN: Rapid activation of NF-κB and AP-1 and target gene expression in postischemic rat intestine. Gastroenterology 118, 525-534 (2000).
40. Nussler NC, Muller AR, Weidenbach H et al.: IL-10 increases tissue injury after selective intestinal ischemia/reperfusion. Ann. Surg. 238, 49-58 (2003).
41. Sonnino R, Ereso G, Arcuni J, Franson R: Human intestinal fatty acid binding protein in peritoneal fluid is a marker of intestinal ischemia. Transplant. Proc. 32, 1280 (2000).
42. Mittak M, Karlik T: Diagnostics of intestinal ischemia. Influence of surgery on plasma levels of I-FABP as the marker of enterocyte injury. Rozhl Chir 87, 16-20 (2008).
43. Polk JD, Rael LT, Craun ML, Mains CW, Davis-Merritt D, Bar-Or D: Clinical utility of the cobalt-albumin binding assay in the diagnosis of intestinal ischemia. J. Trauma 64, 42-45 (2008).
44. Welborn MB, Oldenburg HS, Hess PJ et al.: The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit. Care Med. 28, 3191-3197 (2000).
45. Foulds S, Galustian C, Mansfield AO, Schachter M: Transcription factor NF-κB expression and postsurgical organ dysfunction. Ann. Surg. 233, 70-78 (2001).
46. Foulds S, Mireskandari M, Kalu P et al.: Visceral ischemia and neutrophil activation in sepsis and organ dysfunction. J. Surg. Res. 75, 170-176 (1998).
47. Altinyollar H, Boyabatli M, Berberoglu U: D-dimer as a marker for early diagnosis of acute mesenteric ischemia. Thromb. Res. 117, 463-467 (2006).
48. Kurt Y, Akin ML, Demirbas S et al.: D-dimer in the early diagnosis of acute mesenteric ischemia secondary to arterial occlusion in rats. Eur. Surg. Res. 37, 216-219 (2005).
49. Schoots IG, Levi M, Roossink EH, Bijlsma PB, van Gulik TM: Local intravascular coagulation and fibrin deposition on intestinal ischemia-reperfusion in rats. Surgery 133, 411-419 (2003).
50. Gunerhan Y, Koksal N, Kayahan M, Eryavuz Y, Sekban H: Diagnostic value of plasminogen activity level in acute mesenteric ischemia. World J. Gastroenterol. 14, 2540-2543 (2008).
51. Gill SR, Pop M, Deboy RT et al.: Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359 (2006).
52. Jia W, Li H, Zhao L, Nicholson JK: Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 7, 123-129 (2008).
53. Hopkins MJ, Macfarlane GT: Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. J. Med. Microbiol. 51, 448-454 (2002).
54. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
55. Eckburg PB, Bik EM, Bernstein CN et al.: Diversity of the human intestinal microbial flora. Science 308, 1635-1638 (2005).
56. Reading NC, Sperandio V: Quorum sensing: the many languages of bacteria. FEMS Microbiol. Lett. 254, 1-11 (2006).
57. Sperandio V, Torres AG, Jarvis B, Nataro JP, Kaper JB: Bacteria-host communication: the language of hormones. Proc. Natl Acad. Sci. USA 100, 8951-8956 (2003).
58. Xing HC, Li LJ, Xu KJ et al.: Intestinal microflora in rats with ischemia/reperfusion liver injury. J. Zhejiang Univ. Sci. B 6, 14-21 (2005).
59. Opal SM, Gluck T: Endotoxin as a drug target. Crit. Care Med. 31, S57-S64 (2003).
60. Swank GM, Deitch EA: Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World. J. Surg. 20, 411-417 (1996).
61. Cicalese L, Billiar TR, Rao AS, Bauer AJ: Interaction between ischemia/ reperfusioninduced leukocyte emigration and translocating bacterial enterotoxins on enteric muscle function. Transplant. Proc. 29, 1815 (1997).
62. Turnage RH, Guice KS, Oldham KT: Endotoxemia and remote organ injury following intestinal reperfusion. J. Surg. Res. 56, 571-578 (1994).
63. Nezu Y, Tagawa M, Sakaue Y, Hara Y, Tsuchida S, Ogawa R: Kinetics of endotoxin concentration and tumor necrosis factor-α, interleukin-1β, and interleukin-6 activities in the systemic and portal circulation during small intestinal ischemia and reperfusion in dogs. Am. J. Vet. Res. 63, 1680-1686 (2002).
64. Souza DG, Vieira AT, Soares AC et al.: The essential role of the intestinal microbiota in facilitating acute inflammatory responses. J. Immunol. 173, 4137-4146 (2004).
65. Cruz N, Lu Q, Alvarez X, Deitch EA: Bacterial translocation is bacterial species dependent: results using the human Caco-2 intestinal cell line. J. Trauma 36, 612-616 (1994).
66. O'Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC: Microbiology of bacterial translocation in humans. Gut 42, 29-35 (1998).
67. Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G: Interferon g induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 128, 1258-1267 (2005).
68. Nazli A, Yang PC, Jury J et al.: Epithelia under metabolic stress perceive commensal bacteria as a threat. Am. J. Pathol. 164, 947-957 (2004).
69. Spahn TW, Kucharzik T: Modulating the intestinal immune system: the role of lymphotoxin and GALT organs. Gut 53, 456-465 (2004).
70. Garside P, Millington O, Smith KM: The anatomy of mucosal immune responses. Ann. NY Acad. Sci. 1029, 9-15 (2004).
71. Song F, Whitacre CC: The role of the gut lymphoid tissue in induction of oral tolerance. Curr. Opin Investig. Drugs 2, 1382-1386 (2001).
72. Ayten R, Dogru O, Camci C, Aygen E, Cetinkaya Z, Akbulut H: Predictive value of procalcitonin for the diagnosis of bowel strangulation. World J. Surg. 29, 187-189 (2005).
73. Papaziogas B, Anthimidis G, Koutelidakis I, Atmatzidis S, Atmatzidis K: Predictive value of procalcitonin for the diagnosis of bowel strangulation. World J. Surg. 32, 1566-1567 (2008).
74. Gunel E, Caglayan O, Caglayan F: Serum D-lactate levels as a predictor of intestinal ischemia-reperfusion injury. Pediatr. Surg. Int. 14, 59-61 (1998).
75. Murray MJ, Gonze MD, Nowak LR, Cobb CF: Serum d(-)-lactate levels as an aid to diagnosing acute intestinal ischemia. Am. J. Surg. 167, 575-578 (1994).
76. Collange O, Tamion F, Chanel S et al.: D-lactate is not a reliable marker of gut ischemia-reperfusion in a rat model of supraceliac aortic clamping. Crit. Care Med. 34, 1415-1419 (2006).
77. Scanlan PD, Shanahan F, Clune Y et al.: Culture-independent analysis of the gut microbiota in colorectal cancer and polyposis. Environ. Microbiol. 10, 789-798 (2008).
78. Dumas ME, Barton RH, Toye A et al.: Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl Acad. Sci. USA 103, 12511-12516 (2006).
79. Nicholson JK, Holmes E, Wilson ID: Gut microorganisms, mammalian metabolism and personalized health care. Nat. Rev. Microbiol. 3, 431-438 (2005).
80. Wang Y, Tang H, Nicholson JK, Hylands PJ, Sampson J, Holmes E: A metabonomic strategy for the detection of the metabolic effects of chamomile (Matricaria recutita L.) ingestion. J. Agric. Food Chem. 53, 191-196 (2005).
81. Holmes E, Nicholson J: Variation in gut microbiota strongly influences individual rodent phenotypes. Toxicol. Sci. 87, 1-2 (2005).
82. Martin FP, Wang Y, Sprenger N et al.: Probiotic modulation of symbiotic gut microbial-host metabolic interactions in a humanized microbiome mouse model. Mol. Syst. Biol. 4, 157 (2008).
83. Clayton TA, Lindon JC, Cloarec O et al.: Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 440, 1073-1077 (2006).
84. 1H NMR spectroscopy for the prediction of therapeutic outcome in patients with fulminant hepatic failure. NMR Biomed. 19, 521-526 (2006).
85. Mayr M, Yusuf S, Weir G et al.: Combined metabolomic and proteomic analysis of human atrial fibrillation. J. Am. Coll. Cardiol. 51, 585-594 (2008).
86. Lindon JC, Holmes E, Bollard ME, Stanley EG, Nicholson JK: Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 9, 1-31 (2004).
87. Constantinou MA, Tsantili-Kakoulidou A, Andreadou I, Iliodromitis EK, Kremastinos DT, Mikros E: Application of NMR-based metabonomics in the investigation of myocardial ischemia-reperfusion, ischemic preconditioning and antioxidant intervention in rabbits. Eur. J. Pharm. Sci. 30, 303-314 (2007).
88. Viant MR, Lyeth BG, Miller MG, Berman RF: An NMR metabolomic investigation of early metabolic disturbances following traumatic brain injury in a mammalian model. NMR Biomed. 18, 507-516 (2005).
89. 1H NMR spectroscopy. Cryobiology 36, 225-235 (1998).
90. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU: H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int. 67, 1142-1151 (2005).
91. Kimmich GA, Randles J, Brand JS: Assay of picomole amounts of ATP, ADP, and AMP using the luciferase enzyme system. Anal. Biochem. 69, 187-206 (1975).
92. 31P magnetic resonance spectroscopy of mesenteric ischemia. Magn. Reson. Med. 4, 83-87 (1987).
93. Taylor BM, Jamieson WG, Durand D: Preinfarction diagnosis of acute mesenteric ischemia by simple measurement of inorganic phosphate in body fluids. Can. J. Surg. 22, 40-45 (1979).
94. Jamieson WG, Marchuk S, Rowsom J, Durand D: The early diagnosis of massive acute intestinal ischaemia. Br. J. Surg. 69, S52-S53 (1982).
95. 31P-MRS. J. Surg. Res. 61, 373-378 (1996).
96. Sato A, Kuwabara Y, Sugiura M, Seo Y, Fujii Y: Intestinal energy metabolism during ischemia and reperfusion. J. Surg. Res. 82, 261-267 (1999).
97. 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin. Chem. 45, 539-548 (1999).
98. Blum H, Summers JJ, Schnall MD et al.: Acute intestinal ischemia studies by phosphorus nuclear magnetic resonance spectroscopy. Ann. Surg. 204, 83-88 (1986).
99. Blum H, Summers JJ, Schnall MD, Leigh JS, Chance B, Buzby GP: Acute occlusive intestinal ischemia studied by phosphorus-31 nuclear magnetic resonance. Curr. Surg. 43, 482-485 (1986).
100. 31)P MRS. J. Surg. Res. 89, 38-42 (2000).
101. Canada AT, Coleman LR, Fabian MA Jr, Bollinger RR: Adenine nucleotides of ischemic intestine do not reflect injury. J. Surg. Res. 55, 416-421 (1993).
102. Temes RT, Kauten RJ, Schwartz MZ: Nuclear magnetic resonance as a noninvasive method of diagnosing intestinal ischemia: technique and preliminary results. J. Pediatr. Surg. 26, 775-779 (1991).
103. Kimura M, Kataoka M, Kuwabara Y, Sato A, Sugiura M, Fujii Y: Real-time energy metabolism of intestine during arterial versus venous occlusion in the rat. J. Gastroenterol. 38, 849-853 (2003).
104. Vejchapipat P, Proctor E, Ramsay A et al.: Intestinal energy metabolism after ischemia-reperfusion: effects of moderate hypothermia and perfluorocarbons. J. Pediatr. Surg. 37, 786-790 (2002).
105. 31)P-MRS. Eur. Surg. Res. 34, 306-312 (2002).
106. Hiratsuka M, Yano M, Mora BN, Nagahiro I, Cooper JD, Patterson GA: Heat shock pretreatment protects pulmonary isografts from subsequent ischemia-reperfusion injury. J. Heart Lung Transplant 17, 1238-1246 (1998).
107. Vejchapipat P, Williams SR, Spitz L, Pierro A: Intestinal metabolism after ischemia-reperfusion. J. Pediatr. Surg. 35, 759-764 (2000).
108. Mitchell SJ, Churchill TA, Winslet MC, Fuller BJ: Effects of different cold preservation solutions on restoration of hepatic energy metabolism during cold reperfusion. Cryobiology 33, 413-422 (1996).
109. Lindon JC, Nicholson JK, Holmes E et al.: Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicol. Appl. Pharmacol. 187, 137-146 (2003).
110. 31)P heteronuclear statistical total correlation spectroscopy of intact human gut biopsies. Anal. Chem. 80, 1058-1066 (2008).
111. 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death. Mol. Syst. Biol. 4, 167 (2008).
112. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E: NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed. 18, 143-162 (2005).
113. Stanley EG, Bailey NJ, Bollard ME et al.: Sexual dimorphism in urinary metabolite profiles of Han Wistar rats revealed by nuclear-magnetic-resonance-based metabonomics. Anal. Biochem. 343, 195-202 (2005).
114. Deitch EA, Ananthakrishnan P, Cohen DB, Xu da Z, Feketeova E, Hauser CJ: Neutrophil activation is modulated by sex hormones after trauma-hemorrhagic shock and burn injuries. Am. J. Physiol. Heart Circ. Physiol. 291, H1456-H1465 (2006).
115. Lindon JC, Nicholson JK, Holmes E et al.: Summary recommendations for standardization and reporting of metabolic analyzes. Nat. Biotechnol. 23, 833-838 (2005).
116. Samani NJ, Burton P, Mangino M et al.: A genomewide linkage study of 1,933 families affected by premature coronary artery disease: The British Heart Foundation (BHF) Family Heart Study. Am. J. Hum. Genet. 77, 1011-1020 (2005).
117. Feezor RJ, Baker HV, Xiao W et al.: Genomic and proteomic determinants of outcome in patients undergoing thoracoabdominal aortic aneurysm repair. J. Immunol. 172, 7103-7109 (2004).
118. Martin SL, Epperson LE, Rose JC, Kurtz CC, Ane C, Carey HV: Proteomic analysis of the winter-protected phenotype of hibernating ground squirrel intestine. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R316-R328 (2008).
119. Lee C, Morton CC: Structural genomic variation and personalized medicine. N. Engl. J. Med. 358, 740-741 (2008).
120. Martin FP, Dumas ME, Wang Y et al.: A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 3, 112 (2007).
121. Knickerbocker T, Chen JR, Thadhani R, MacBeath G: An integrated approach to prognosis using protein microarrays and nonparametric methods. Mol. Syst. Biol. 3, 123 (2007).
122. Kurimoto Y, Kawaharada N, Ito T, Morikawa M, Higami T, Asai Y: An experimental evaluation of the lactate concentration following mesenteric ischemia. Surg. Today 38, 926-930 (2008).
123. Caglayan F, Caglayan O, Gunel E, Elcuman Y, Cakmak M: Intestinal ischemia-reperfusion and plasma enzyme levels. Pediatr. Surg. Int. 18, 255-257 (2002).
124. Koike K, Yamamoto Y, Hori Y, Ono T: Group IIA phospholipase A2 mediates lung injury in intestinal ischemia-reperfusion. Ann. Surg. 232, 90-97 (2000).
125. de Arruda MJ, Poggetti RS, Fontes B, Younes RN, Souza AL, Birolini D Jr: Intestinal ischemia/reperfusion induces bronchial hyperreactivity and increases serum TNF-α in rats. Clinics 61, 21-28 (2006).
126. Yamamoto S, Tanabe M, Wakabayashi G, Shimazu M, Matsumoto K, Kitajima M: The role of tumor necrosis factor-a and interleukin-1β in ischemia-reperfusion injury of the rat small intestine. J. Surg. Res. 99, 134-141 (2001).
127. Wang JY, Cheng KI, Yu FJ, Tsai HL, Huang TJ, Hsieh JS: Analysis of the correlation of plasma NO and ET-1 levels in rats with acute mesenteric ischemia. J. Invest. Surg. 19, 155-161 (2006).
128. Juvonen PO, Paajanen HE, Heino AA et al.: Lipid peroxidation products and antioxidant capacity in portal venous and systemic arterial plasma during gradual intestinal ischemia and reperfusion in pigs. Eur. Surg. Res. 30, 95-101 (1998).
129. Vejchapipat P, Williams SR, Proctor E, Lauro V, Spitz L, Pierro A: Moderate hypothermia ameliorates liver energy failure after intestinal ischaemia-reperfusion in anaesthetized rats. J. Pediatr. Surg. 36, 269-275 (2001).